Eli Lilly Market Cap 2006-2019 | LLY

Eli Lilly market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Eli Lilly market cap as of January 17, 2020 is $135.79B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $135.791B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.044B 16.90
Roche Holding AG (RHHBY) Switzerland $285.924B 0.00
Merck (MRK) United States $232.143B 17.98
Pfizer (PFE) United States $224.741B 13.36
Novartis AG (NVS) Switzerland $217.950B 18.40
Novo Nordisk (NVO) Denmark $145.182B 25.02
AstraZeneca (AZN) United Kingdom $132.526B 23.94
AbbVie (ABBV) United States $132.000B 10.34
Sanofi (SNY) France $128.187B 15.75
GlaxoSmithKline (GSK) United Kingdom $117.627B 14.25
Bristol-Myers Squibb (BMY) United States $108.804B 15.21
Bayer (BAYRY) Germany $78.260B 11.59
H Lundbeck (HLUYY) Denmark $8.184B 11.81